Title : Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer.

Pub. Date : 2015

PMID : 26181325






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We used a nonlinear ordinary differential equation model to support the idea that PIK3CA mutations act as downstream activators of AKT that blunt lapatinib inhibition of downstream AKT signaling and that the effects of PIK3CA mutations can be countered by combining lapatinib with an AKTi. Lapatinib AKT serine/threonine kinase 1 Homo sapiens
2 We used a nonlinear ordinary differential equation model to support the idea that PIK3CA mutations act as downstream activators of AKT that blunt lapatinib inhibition of downstream AKT signaling and that the effects of PIK3CA mutations can be countered by combining lapatinib with an AKTi. Lapatinib AKT serine/threonine kinase 1 Homo sapiens
3 We used a nonlinear ordinary differential equation model to support the idea that PIK3CA mutations act as downstream activators of AKT that blunt lapatinib inhibition of downstream AKT signaling and that the effects of PIK3CA mutations can be countered by combining lapatinib with an AKTi. Lapatinib AKT serine/threonine kinase 1 Homo sapiens